Psyence Group said Thursday it has closed the disposal of its 11.13% stake in privately held PsyLabs to its associate, Psyence Biomedical (PBM).
Psyence Biomedical will issue 2 million shares to Psyence Group as part of the deal, the company said.
Additionally, Psyence Biomedical has issued 845,394 of its shares to Psyence Group following a debt-for-equity swap agreement, according to the statement.
Shares of Psyence Biomedical plunged about 24% in recent trading.
Price: 0.07, Change: -0.02, Percent Change: -24.47
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。